Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $268,613 - $291,571
-4,783 Reduced 19.64%
19,565 $1.19 Million
Q2 2024

Aug 12, 2024

BUY
$53.58 - $57.02 $857,119 - $912,148
15,997 Added 191.56%
24,348 $1.37 Million
Q1 2024

May 13, 2024

BUY
$42.56 - $59.82 $355,418 - $499,556
8,351 New
8,351 $471,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $95,643 - $201,914
3,002 Added 44.43%
9,759 $423,000
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $307,038 - $501,774
6,757 New
6,757 $444,000
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $396,672 - $518,813
4,549 New
4,549 $488,000
Q2 2021

Aug 12, 2021

SELL
$100.34 - $115.69 $302,525 - $348,805
-3,015 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $306,052 - $377,689
3,015 New
3,015 $318,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.